These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12202219)

  • 1. Expression of HCV structural proteins impairs IFN-mediated antiviral response.
    Keskinen P; Melén K; Julkunen I
    Virology; 2002 Aug; 299(2):164-71. PubMed ID: 12202219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of hepatitis C virus proteins interferes with the antiviral action of interferon independently of PKR-mediated control of protein synthesis.
    François C; Duverlie G; Rebouillat D; Khorsi H; Castelain S; Blum HE; Gatignol A; Wychowski C; Moradpour D; Meurs EF
    J Virol; 2000 Jun; 74(12):5587-96. PubMed ID: 10823866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase.
    Gale M; Kwieciszewski B; Dossett M; Nakao H; Katze MG
    J Virol; 1999 Aug; 73(8):6506-16. PubMed ID: 10400746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of interferon-induced antiviral activity in cells expressing hepatitis C virus proteins.
    Aizaki H; Saito S; Ogino T; Miyajima N; Harada T; Matsuura Y; Miyamura T; Kohase M
    J Interferon Cytokine Res; 2000 Dec; 20(12):1111-20. PubMed ID: 11152578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NS5A protein of hepatitis C virus partially inhibits the antiviral activity of interferon.
    Song J; Fujii M; Wang F; Itoh M; Hotta H
    J Gen Virol; 1999 Apr; 80 ( Pt 4)():879-886. PubMed ID: 10211956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the nonstructural protein 4B of hepatitis C virus as a factor that inhibits the antiviral activity of interferon-alpha.
    Xu J; Liu S; Xu Y; Tien P; Gao G
    Virus Res; 2009 Apr; 141(1):55-62. PubMed ID: 19185598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response.
    Polyak SJ; Khabar KS; Paschal DM; Ezelle HJ; Duverlie G; Barber GN; Levy DE; Mukaida N; Gretch DR
    J Virol; 2001 Jul; 75(13):6095-106. PubMed ID: 11390611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral effects of the interferon-induced protein guanylate binding protein 1 and its interaction with the hepatitis C virus NS5B protein.
    Itsui Y; Sakamoto N; Kakinuma S; Nakagawa M; Sekine-Osajima Y; Tasaka-Fujita M; Nishimura-Sakurai Y; Suda G; Karakama Y; Mishima K; Yamamoto M; Watanabe T; Ueyama M; Funaoka Y; Azuma S; Watanabe M
    Hepatology; 2009 Dec; 50(6):1727-37. PubMed ID: 19821486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of antiviral effect of type I, II, and III interferons on direct-acting antiviral-resistant hepatitis C virus.
    Hamana A; Takahashi Y; Uchida T; Nishikawa M; Imamura M; Chayama K; Takakura Y
    Antiviral Res; 2017 Oct; 146():130-138. PubMed ID: 28864074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daclatasvir Prevents Hepatitis C Virus Infectivity by Blocking Transfer of the Viral Genome to Assembly Sites.
    Boson B; Denolly S; Turlure F; Chamot C; Dreux M; Cosset FL
    Gastroenterology; 2017 Mar; 152(4):895-907.e14. PubMed ID: 27932311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the effects of hepatitis C virus nonstructural 5A protein expression in human cell lines and on interferon-sensitive virus replication.
    Polyak SJ; Paschal DM; McArdle S; Gale MJ; Moradpour D; Gretch DR
    Hepatology; 1999 Apr; 29(4):1262-71. PubMed ID: 10094974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal analysis of the 5'UTR, E2-PePHD and NS5A-PKRBD genomic regions of hepatitis C virus genotype 1a in association with the response to peginterferon and ribavirin therapy in HIV-coinfected patients.
    Bolcic F; Laufer N; Torres C; Cassino L; Reynoso R; Quarleri J
    Antiviral Res; 2012 Aug; 95(2):72-81. PubMed ID: 22683884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuralized E3 Ubiquitin Protein Ligase 3 Is an Inducible Antiviral Effector That Inhibits Hepatitis C Virus Assembly by Targeting Viral E1 Glycoprotein.
    Zhao Y; Cao X; Guo M; Wang X; Yu T; Ye L; Han L; Hei L; Tao W; Tong Y; Xu Y; Zhong J
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30111563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of alpha interferon-induced envelope mutations of hepatitis C virus in vitro associated with increased viral fitness and interferon resistance.
    Serre SB; Krarup HB; Bukh J; Gottwein JM
    J Virol; 2013 Dec; 87(23):12776-93. PubMed ID: 24049176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus: the role of molecular mimicry in response to interferon treatment.
    Uzicanin S; Hu YW; Alsousi H; Pelchat M; Rocheleau L; Nair RC; Brown EG
    J Med Virol; 2012 Oct; 84(10):1571-85. PubMed ID: 22930505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiling of the cellular transcriptional network regulated by alpha/beta interferon and its partial attenuation by the hepatitis C virus nonstructural 5A protein.
    Geiss GK; Carter VS; He Y; Kwieciszewski BK; Holzman T; Korth MJ; Lazaro CA; Fausto N; Bumgarner RE; Katze MG
    J Virol; 2003 Jun; 77(11):6367-75. PubMed ID: 12743294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations.
    Pawlotsky JM; Germanidis G; Neumann AU; Pellerin M; Frainais PO; Dhumeaux D
    J Virol; 1998 Apr; 72(4):2795-805. PubMed ID: 9525599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repression of the PKR protein kinase by the hepatitis C virus NS5A protein: a potential mechanism of interferon resistance.
    Gale MJ; Korth MJ; Katze MG
    Clin Diagn Virol; 1998 Jul; 10(2-3):157-62. PubMed ID: 9741641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of viral amino acid substitutions and host interleukin-28b polymorphism on replication and susceptibility to interferon of hepatitis C virus.
    Hiraga N; Abe H; Imamura M; Tsuge M; Takahashi S; Hayes CN; Ochi H; Tateno C; Yoshizato K; Nakamura Y; Kamatani N; Chayama K
    Hepatology; 2011 Sep; 54(3):764-71. PubMed ID: 21618576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of interferon-related promoter activation by hepatitis C virus proteins expressed in cultured cells.
    Hiramatsu A; Gotoh B; Fujii Y; Yoshida T; Chayama K; Sakaguchi T
    Hiroshima J Med Sci; 2006 Sep; 55(3):71-7. PubMed ID: 16995492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.